Sort
261,768 grants matching “gene therapy”
Genetic Variants, Epigenome and Retinal Disease Phenotypes
$2,781,377Anand Swaroop · National Eye Institute · ZIA · FY2016 · EY
Pharmacogenetics of Anticancer Agents Research Group
$2,781,123Mark J Ratain · University Of Chicago · U01 · FY2008 · GM
Molecular profiling and immunomodulatory interventions
$2,780,168Abraham Na Shaked · University Of Pennsylvania · U01 · FY2007 · AI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,779,530Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Genes And Gene Products As Immunoadjuvants
$2,779,404Steven M Holland · Niaid Extramural Activities · Z01 · FY2007 · AI
CALIFORNIA TEACHERS STUDY
$2,778,527Leslie Bernstein · University Of Southern California · R01 · FY2007 · CA
The Vascular Fibroblast: An Understudied Culprit In Postoperative Venous Stenosis
$2,777,206Laisel Martinez · University Of Miami School Of Medicine · R01 · FY2025 · DK
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury
$2,776,920Yow-Pin Lim · Prothera Biologics, Llc · R44 · FY2023 · NS
Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration
$2,776,711Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2017 · AG
"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"
$2,776,459Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2020 · HG
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY
$2,776,081Vanderbilt University · U01 · FY2003 · HL
Genomics of Acute Myelogenous Leukemia
$2,775,922Timothy J Ley · Washington University · P01 · FY2009 · CA
1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
$2,775,824Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · UH3 · FY2020 · HL
Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses
$2,775,679James E Crowe · University Of Texas Med Br Galveston · U19 · FY2020 · AI
Synergies among inhibitory receptors in tolerance and disease
$2,775,439Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI
Protection of Ischemic Myocardium
$2,774,979Roberto Bolli · University Of Louisville · P01 · FY2017 · HL
Pharmacogenomics of Arrhythmia Therapy
$2,772,165Dan M Roden · Vanderbilt University · U01 · FY2009 · HL
Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC)
$2,770,869Merit E Cudkowicz · Massachusetts General Hospital · U01 · FY2025 · NS
Molecular pathological epidemiology of colorectal cancer
$2,769,837Ulrike Peters · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA
Multi-Scale Investigations of Respiratory Mucus/Mucin Structure and Function in Health and Disease
$2,769,140Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2022 · HL
Pharmaceutical Research Center
$2,768,582Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2010 · RR
Innate and Adaptive Immunity in Experimental and Human Gonoccocal Infection
$2,768,529Peter A. Rice · Univ Of Massachusetts Med Sch Worcester · U19 · FY2012 · AI
Genetic and clinical studies of Gaucher disease and other lysosomal disorders
$2,768,333Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2024 · HG
DCTD Computer Support
$2,767,982David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
UCLA Center for AIDS Research (CFAR)
$2,767,328Jerome A. Zack · University Of California Los Angeles · P30 · FY2014 · AI